VEGFD and lymphangioleiomyomatosis: VEGF‐D is a diagnostic biomarker, and an elevated serum level (≥800 pg/mL) can help confirm the diagnosis of LAM in women with a compatible medical history and characteristic CT scan of the chest [16].